中粮科技(000930) - 2020 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders decreased by 17.11% to CNY 168,337,560.20 for the reporting period[9] - Operating revenue for the reporting period was CNY 4,679,083,110.23, a decrease of 6.27% year-on-year[9] - Basic earnings per share decreased by 17.11% to CNY 0.0911 for the reporting period[9] - The weighted average return on net assets was 1.67%, down 21.94% compared to the previous year[9] - The company reported a net profit excluding non-recurring gains and losses of CNY 160,547,269.65, an increase of 18.57% year-on-year[9] - Operating revenue for the reporting period was 4,679,083,110.23, a decrease of 6.27% compared to 4,992,268,130.59 in the same period last year[22] - Operating costs decreased by 3.68% to 4,157,459,446.91 from 4,316,302,061.47 year-on-year[22] - The company reported a net profit of CNY 1,564,276,714.26, compared to CNY 1,060,381,957.50 in the previous year, marking a significant increase of approximately 47.5%[49] - Net profit for the current period is ¥181,322,544.35, a decrease of 7.8% compared to ¥196,781,000.27 in the previous period[61] - Net profit for the current period is ¥406,937,895.73, up 72.3% from ¥235,990,134.48 in the previous period[86] Cash Flow - The net cash flow from operating activities decreased significantly by 88.26% to CNY 269,215,196.15[9] - Net cash flow from operating activities turned negative at -17,750,883.66, a decline of 100.47% compared to 3,812,330,590.92 in the same period last year[22] - The net increase in cash and cash equivalents was -85,595,603.30, a decline of 108.19% compared to 1,045,631,585.13 in the same period last year[22] - Cash flow from operating activities decreased to -¥17,750,883.66, compared to ¥3,812,330,590.92 in the previous period, indicating a significant decline[90] - The company recorded investment income of ¥213,725,877.15, a substantial increase from ¥31,040,922.40 in the previous period[82] - Cash inflow from investment activities was ¥491,553,839.03, up from ¥237,977,130.23, reflecting increased returns from investments[97] Assets and Liabilities - Total assets increased by 3.25% to CNY 17,713,693,077.16 compared to the end of the previous year[9] - Total current assets increased to 7,327,016,030.25 from 6,727,876,548.28 year-on-year[40] - Current liabilities totaled CNY 6,647,578,754.68, slightly up from CNY 6,541,248,372.07, indicating a 1.6% increase[46] - Total liabilities amounted to CNY 6,994,222,399.59, a slight increase from CNY 6,953,954,345.96, showing a growth of about 0.6%[49] - The company's total non-current assets amounted to CNY 10,386,677,046.91, slightly down from CNY 10,428,986,154.24, indicating a decrease of about 0.4%[49] - Total liabilities amount to ¥1,489,028,121.79, a decrease from ¥1,709,342,650.84 in the previous period[56] - The total assets amount to ¥11,788,450,942.63, an increase from ¥11,629,678,668.77 in the previous period[56] Shareholder Information - The total number of shareholders at the end of the reporting period was 160,895[13] - The largest shareholder, COFCO Bio-chemical Investment Co., Ltd., held 47.34% of the shares[13] Research and Development - Research and development investment increased significantly by 191.01% to 46,259,831.48 from 15,896,570.87 in the previous year[22] - Research and development expenses for the current period are ¥46,259,831.48, significantly higher than ¥15,896,570.87 in the previous period, indicating increased investment in innovation[61] - Research and development expenses increased to ¥36,432,161.96, up 80.3% from ¥20,194,535.73 in the previous period[82] Comprehensive Income - Other comprehensive income after tax for the current period is -¥32,450,014.65, compared to ¥74,325,553.11 in the previous period, showing a substantial decline[65] - The company reported a total comprehensive income of ¥148,872,529.70 for the current period, down from ¥271,106,553.38 in the previous period[65] - The company reported a total comprehensive income of ¥528,717,611.50, an increase of 16.9% from ¥451,925,602.64 in the previous period[81] Strategic Initiatives - The company plans to expand its market presence and invest in new product development to drive future growth[108] - The company is focusing on strategic acquisitions to enhance its competitive position in the industry[108]